It was in talks to invest in the firm last year too but other investors clinched the deal.
This is its first funding in a Tier II market.
It is an arm of public listed Patel Engineering.
VRL's shares are expected to be listed on stock exchanges this week.
The investment is for a mid-income housing project.
This is the second exit activity by Khazanah in India after it sold Yes Bank stake in 2012.
The group has been laden with debt and has been looking to sell assets.
It has shelled out around $200 million in total for Nirlon.
The proposed stake sale comes ahead of L&T's plans to list its technology subsidiaries.
The PE firm already owns a majority stake in CARE.
Titagarh was previously also backed by ChrysCap, 2i Capital and JP Morgan Partners.
It had invested in the company three years ahead of its IPO in 2010.
The fund is eyeing operating toll road assets in India.
Claris also counts Signet and OrbiMed as PE shareholders.
It had exited the firm in 2010-11, losing almost two-thirds of its initial investment made in 2005.
The developer recently raised Rs 1,200 crore for its flagship project Worli 1973.
It has previously backed Indian PE firms such as CX Partners, Tano Capital and ChrysCap.
This is the third-largest PE deal ever in Indian pharma and the top fundraiser in the industry.
The PE firm had invested in the private lender in 2012.
This is the first known investment by Apax in this year in India.
Really, appreciable step by RBI.
Startups should be primarily focussed on generating cash. Valuation will follow.
Great news.. So good to see some genuine quality product and brand owners getting backed, rather than just...
One of the worst case history created for India starting from Ranbaxy sale in 2008. Sorry to see this. Doesn't do...